Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 21;23(10):e27714. doi: 10.2196/27714

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©Adam Lavertu, Tymor Hamamsy, Russ B Altman. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 21.10.2021.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.

PMC Copyright notice

DRIP scores calculated using side effect severity and frequency. (A) DRIP scores (x-axis) for ATC classification system groups (y-axis) ordered by median severity with outliers labeled. The dashed blue line indicates the median DRIP score of 0.439 across all drugs. (B) DRIP scores (x-axis) for opioid class drugs (y-axis), as denoted by the N02A ATC group. Fentanyl, an extremely potent synthetic opioid, is ranked first as having the most severe side effect. (C) DRIP scores (x-axis) for statins (y-axis), as denoted by the C10AA ATC group. Atorvastatin, the strongest statin in broad use, is ranked to have the most severe side effect, whereas lower-efficacy statins are ranked as having less-severe side effects. ATC: Anatomical Therapeutic Chemical; DRIP: drug-risk profile.